Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human TAS2R38 ELISA Kit (AC2644)
Cat.#: ASET-1233
Specifications
Description Human TAS2R38 ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human TAS2R38 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1037 Mouse GBA ELISA Kit (AC2448) Quantitative inquiry ASET-2311 Human GAD65 ELISA Kit (AC3722) Quantitative inquiry ASET-2227 Human PON2 ELISA Kit (AC3638) Quantitative inquiry ASET-1312 Bovine Adiponectin ELISA Kit (AC2723) Quantitative inquiry ASET-2046 Human Activin B ELISA Kit (AC3457) Quantitative inquiry ASET-2415 Mouse Substance P ELISA Kit (AC3826) Quantitative inquiry ASET-1925 Human MERTK ELISA Kit (AC3336) Quantitative inquiry ASET-1530 Human Neuritin ELISA Kit (AC2941) Quantitative inquiry ASET-1447 Human RAMP1 ELISA Kit (AC2858) Quantitative inquiry ASET-1901 Mouse CRMP2 ELISA Kit (AC3312) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket